Welcome to the IoT Slam® Internet of Things Conference - The world's most trusted IoT event brand
|

Single Blog Title

This is a single blog caption
25
Oct

BioIntelliSense Nomination

What is the business/industrial problem they are solving?

Through their IoT enabled wearable BioButton, BioIntelliSense is addressing the nursing labor shortage and burden through intelligent automation of in-patient to home vital sign collection.

Who are the targeted customers?

Health Systems / Providers, Payers, Pharma, Medtech Companies

Please provide evidence of how the nominated company demonstrates contribution to ROI generation and fast time-to-market in Healthcare from the adoption of IoT solutions.

The BioIntelliSense comprehensive portfolio of tech-enabled care solutions make continuous vital sign monitoring efficient, reliable and cost-effective from in-hospital to home. Its medical grade acute and post-acute solutions empower clinicians with up to 1,440 high frequency trending measurements per day, versus episodic manually collected vital signs 4-6 times per day (@ $1000k/day/nurse vs. $3/biobutton), to enable early detection of clinical patient deterioration. Coupled with the company’s advanced data analytics and AlertWatch clinical intelligence engine, this system enables scalable, continuous in-facility and home patient monitoring at a fraction of the cost relative to manually measured traditional care. Opportunities for earlier detection of clinical problems
• Reduce length of stay in hospitals
• Improve patient outcomes in-hospital and at home
• Address nurse labor cost and workforce efficiencies

Demonstrate how nominated company contributes to the effective adoption and advancement of IoT solutions by enhancing sustainability in Healthcare practices.

They are LTE/5G cellular enabled, wifi and ble enabled. Capturing data at the edge for near-real time point of care insights. The company’s comprehensive portfolio of award-winning, medical-grade monitoring and analytics solutions enables scalable individualized care when and where it’s most effective.

How has the nominated company demonstrated an ability to scale its services/offerings in a cost-effective manner to meet the needs of its customers?

Deployed in 70+ of the largest health systems and Medtech companies (i.e. Medtronics). Awards as proof points: 2023 Best Overall Medical Device Company in 7th Annual MedTech Breakthrough Awards Program. And, awarded the CES Innovation Award in 2021 and 2023.